The use of hyalomatrix PA in the treatment of extravasation affecting premature neonates

Plast Reconstr Surg. 2012 Jan;129(1):219e-221e. doi: 10.1097/PRS.0b013e3182365e16.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Extravasation of Diagnostic and Therapeutic Materials / drug therapy
  • Extravasation of Diagnostic and Therapeutic Materials / therapy*
  • Female
  • Humans
  • Hyaluronic Acid / metabolism
  • Infant, Newborn
  • Infant, Premature*
  • Infusion Pumps
  • Infusions, Intravenous / adverse effects
  • Male
  • Skin / pathology
  • Skin, Artificial*

Substances

  • Hyaluronic Acid